The objective of this study was to measure the umbilical cord plasma levels of cocaine, nicotine, caffeine, and their metabolites. Thirty-six neonates at risk for prenatal cocaine exposure were prospectively enrolled. Umbilical cord plasma was analyzed by gas chromatography--mass spectroscopy for cocaine, cocaethylene, benzoylecgonine (BZE)r nicotine, cotinine, and caffeine. Eighteen neonates were plasma positive for BZE, and 50% of these were also positive for cocaine. Cocaethylene was not found. The maximum plasma cocaine concentration was 88 ng/mL (mean, 39 ng/mL). The maximum plasma BZE concentration was 3880 ng/mt (mean, 844 ng/mL). Among BZE-positive babies, the mean plasma drug levels were as follows: nicotine, 1.8 ng/mL; cotinine, 94 ng/mL; and caffeine, 1205 ng/mt. Among the BZE-negative babies, the mean plasma drug levels were as follows: nicotine, 5.2 ng/mL; cotinine, 97 ng/mL; and caffeine, 1440 ng/mL. These cocaine levels raise the possibility of pharmacological effects of cocaine in the early neonatal period.
Introduction
Typical signs attributed to neonatal cocaine withdrawal or abstinence syndrome are transient irritability, tremors, and hypertonicity (1) . In an adult, these signs would suggest the presence of cocaine (2) , and they might also suggest the presence of cocaine in a newborn. Umbilical cord plasma levels of cocaine in newborns have not been previously reported. The primary objective of this study was to determine the plasma concentrations of cocaine, cocaethylene, and benzoylecgonine (BZE) in neonates at risk for prenatal cocaine exposure. Cocaethylene is formed by the liver in the presence of cocaine and ethanol and is considered to be pharmacologically active (1, 4) .
Most cocaine-exposed neonates are also exposed to two other sympathomimetics, caffeine and nicotine. Caffeine is nearly universally consumed by pregnant women, and 7596 or more of pregnant cocaine users also smoke cigarettes. Nicotine and cocaine have similar adverse events associated with their use during pregnancy (7, 8) . A secondary objective of the study was to determine the concentrations of nicotine, its metabolite cotinine, and caffeine in umbilical cord plasma from neonates at risk for cocaine exposure.
Methods

Study site, population, and subjects
San Francisco General Hospital (SFGH) is the county hospital, serving ethnically diverse, predominantly lower socioeconomic-status patients who are uninsured or government insured. At SFGH, urine toxicology screens are obtained on all neonates born to mothers who have a risk factor for illicit-drug use, regardless of race or socioeconomic status. The risk factors are as follows: no prenatal care (PNC); teenager with poor PNC; premature delivery with poor PNC; obstetrical suspicion (e.g., abruptio); intrauterine growth retardation; history of drug use in the mother or father; history of prostitution or sexually transmitted diseases; history of incarceration in the mother or father; major psychiatric diagnosis (e.g., schizophrenia); and family violence. For this study, neonates were enrolled if all of the following criteria were met: maternal risk factor for illicit drug use; umbilical cord blood collected at the time of birth; birth weight over 2000 g; and neonate not admitted to the Neonatal Intensive Care Unit. Maternal consent to participate in a research study was obtained postpartum. The study was approved by the University of California, San Francisco, Committee on Human Research.
Umbilical cord plasma collection
Umbilical cord blood was collected prospectively. The cord was double-clamped and cut. The placental side was briefly unclarnped, and the blood was drained into a 60-mL syringe. The blood was then transferred into a glass tube containing both sodium fluoride and potassium oxalate and refrigerated. Plasma was separated and frozen (-25~ until analysis. The blood collected was a mixture of umbilical cord venous and arterial blood and was of fetal/neonatal origin.
Urine collection and validation
Urine samples were usually collected after the SFGH urine toxicology screen collection was completed. Urine was collected in Pampers Premie Diapers. Diaper batting was removed and placed in a 60-mL syringe, and the urine was expelled under pressure from the plunger. The sample was acidified with sodium bisulfate and frozen at-20~ until analysis. In order to be sure that diaper batting did not alter the concentration of cocaine or its metabo-]ites, urine spiked with known concentrations of cocaine and BZE (50 mg/mL, 300 ng/mL, 1000 ng/mL, and 10,000 ng/mL) was placed into Pampers Premie Diapers for 4 h at 37~ The spiked urine was removed from the diapers and analyzed by the same methods used in this study. Recovery of cocaine and benzoylecgonine from the diaper was 80-99% and was not concentration dependent.
Quantitative determination of cocaine, BZE, nicotine, cotinine, and caffeine
Concentrations of cocaine and its metabolite, BZE, in plasma and urine were determined by a modification of the method of Jacob et al. (9) . The modification used deuterium-labeled analogues, cocaine-d3 and BZE-d3, as internal standards and quantitation with combined gas chromatography-mass spectrometry (GC-MS) with selected ion monitoring of the molecular ions of the analytes and internal standards. The method was also capable of detecting the ethanol-derived metabolite, cocaethylene. The limits of quantitation were 5 ng/mL for cocaine and BZE and 10 ng/mL for cocaethylene. Concentrations of nicotine, cotinine, and caffeine in plasma were determined by GC with nitrogen-phosphorus detection (10) using 5-methylnicotine, 1-methyl-5-(2-pyridyl)-pyrrolidin-2-one (ortho-cotinine), and 7-ethyltheophylline as internal standards. This method has been modified for simultaneous extraction of nicotine, cotinine, and caffeine and determination using capillary GC (11) . The limits of quantitation were 1 ng/mL for nicotine and 10 ng/mL for cotinine and caffeine.
Qualitative hospital urine toxicology screening
Analysis was done by the SFGH clinical laboratory. I\ypically, the hospital urine toxicology screen was collected during the first 24 h of life, immediately before beginning the research urine sample collection. The urine was screened for BZE by an enzyme immunoassay (EMIT, Emit-Dau Syva Co., Palo Alto, CA) and for cocaine by both thin-layer chromatography (Toxi-Lab, Analytical Systems, Irvine, CA) and GC (12) . The cutoff for positive screens for BZE was 300 ng/mL and 150 ng/mL for cocaine by GC.
Data and statistical analysis
Student t test for ordinal data and Chi square for categorical data were used to test for statistical significance. Time interval between birth (cord blood collection) and the collection of the urine research sample. * NDD --No drug detected at the limits of quantitation, 5 ng/mL cocaine and benzoylecgonine, 1 ng/mL nicotine, and 10 ng/mL cotinine and caffeine.
Results
Patient characteristics
Thirty-six neonates were enrolled, and 18, or half, of the neonates enrolled had umbilical cord plasma positive for BZE. The umbilical cord plasma BZE-positive neonatal cohort had the following characteristics: lack of prenatal care, 61%; mean birth weight, 2920 g (SD + 506); mean head circumference, 33.2 cm (SD • 1.4); and Mrican-Arnerican race, 72%. The umbilical cord plasma BZE-negative cohort had the following characteristics: lack of prenatal care, 31%; mean birth weight, 3349 g (SD • 345); mean head circumference, 34.8 cm (SD • 1.2); and African-American race, 38%. There were statistically significant differences between the positive and negative groups for birth weight (p = 0.01), head circumference (p = 0.002), African-American race (p = 0.04), and prenatal care (p < 0.05). All enrolled neonates had 5-min apgars of 8 or greater.
Plasma and urine cocaine and metabolite concentrations
The plasma and urine concentrations of cocaine and BZE and the hospital urine toxicology results are in Table I . No cocaethylene was measurable at the 10-ng/mL quantitation level in plasma or urine. Fifty percent of the BZE-positive umbilical cord plasma samples were also positive for cocaine. The mean plasma cocaine concentration was 39 ng/mL (SD • 32), whereas the mean urine cocaine concentration was 87 ng/mL (SD + 78). The mean plasma BZE concentration was 843 ng/mL (SD • 1030), whereas the mean urine BZE concentration was 5200 ng/mL (SD • 10,000). The mean time interval between birth and collection of the research urine sample was 28 h (SD • 19). All subjects with BZE-negative plasma samples had BZE-negative urine samples and BZE-negative neonatal hospital toxicology screens. All subjects with BZE-positive plasma samples had BZE-positive urine samples, and 88% also had a BZE-positive neonatal hospital toxicology screen. The two neonates with the highest and third highest concentrations of cocaine in their plasma had urine screens positive for both cocaine and BZE.
Nicotine, cotinine, and caffeine plasma levels
Thirty-one of the 36 cord blood samples were also assayed for nicotine, its metabolite cotinine, and caffeine. These results are in Table II . Among BZE-positive neonates, the mean nicotine plasma concentration was 2.8 ng/mL (SD • 1.3), the mean cotinine plasma concentration was 94 ng/mL (SD • 65), and the mean caffeine plasma concentration was 1205 ng/mL (SD • 3030). Among the BZE-negative neonates, the mean nicotine concentration was 5.2 ng/mL (SD • 6.2), the mean cotinine concentration was 97 ng/mL (SD + 94), and the mean caffeine plasma concentration was 1440 ng/mL (SD + 2600). A trend toward higher caffeine concentrations in the BZE-negative group was evident but not statistically significant. This is the first report of plasma cocaine concentrations in a group of neonates. The BZE plasma levels reported here are substantially higher than previous reports (4, 14, 15) . Cocaine was present in the plasma of 50% of the BZE-positive neonates, and 33% of BZE-positive neonates had plasma BZE levels between 1000 and 4000 ng/mL. Konkol et al. (4) retrieved 11 umbilical cord bloods that were collected for routine neonatal tests and assayed them for cocaine and BZE; cocaine was not found, and the maximum BZE concentration was 1370 ng/mL (4). Henderson et al. (14) assayed 545 neonatal blood samples collected for inborn errors of metabolism, and 24 were positive for BZE with a maximum concentration of 250 ng/mL. Moore et al. (15) reported umbilical cord blood levels in a premature baby that lived; cocaine was not detectable, and the BZE level was 1200 ng/mL. The differences between the newborn levels reported here and previous reports are probably due to the method of collection. In previous studies, samples were collected for other purposes and later used for research purposes (4, 14) . In this study, samples were prospectively collected into tubes containing both potassium oxalate and sodium fluoride, which prevented metabolism and spontaneous hydrolysis of cocaine and its metabolites (16) . Substantial and rapid in vitro metabolism of cocaine occurs postcollection if samples are not properly treated (16) .
Discussion
The Los Angeles Coroner's office reported 17 stillbirths attributed to maternal cocaine use after other causes were excluded (e.g., infection, congenital malformations, trauma) (17) . One stillbirth had a cocaine blood level of 4200 ng/mL, which is likely a lethal level in an adult. All remaining blood levels were under 500 ng/mL, and the median cocaine level was 170 ng/mL (17) . The median stillbirth blood BZE concentration was 1090 ng/mL, and the maximum was 4300 ng/mL (17) . The BZE levels in stillbirths were in the same range as this study. The plasma BZE concentrations reported lO,200 here are similar to those reported in adults 669 (18) (19) (20) . The umbilical cord plasma cocaine 1180 concentrations are consistent with pharmaco-1580 logic activity, although they are not as high as those enrolling in cocaine-dependence treat48o 444 ment programs (19) , and chronic cocaine users 439 in methadone-maintenance programs (20) .
324
Transient agitation, tremors, hypertonicity, 207 and other abnormal signs in cocaine-exposed neonates have commonly been attributed to drug withdrawal (1) . Similar signs in an adult would be attributed to cocaine intoxication. Cocaine withdrawal in an adult is essentially a behavioral syndrome characterized by lethargy and depression (2) . The neonatal plasma levels reported here raise the possibility that some transient clinical abnormalities observed after birth may represent continuing drug intoxication (1, 4) . The presence of cocaine on a hospital urine screen indicates cocaine exposure proximate to the time of testing (21) . Toxicology urine screens positive for both cocaine and benzoylecgonine have been used to identify children with acute cocaine intoxication (22) . In this study, the neonates with the highest and third highest plasma concentrations of cocaine had cocaine detectable on their hospital urine screen. We reviewed 5 years of SFGH newborn urine toxicology screens. Approximately 17% of newborns positive for BZE on the urine screens were also positive for cocaine. If there are signs associated with the presence of cocaine in the neonate, then the number of neonates affected may not be insignificant.
Most neonates in this study were also prenatally exposed to two other sympathomimetics, nicotine and caffeine. Maternal cigarette smoking confounds all studies investigating the effects of prenatal cocaine exposure. Maternal plasma concentrations of cotinine inversely correlate with decreased birth weights in smokers compared with nonsmokers (23) . Umbilical cord blood is a noninvasive sample because it is obtained from the placenta, and it is collected from every subject at exactly the same time, birth. In research studies, umbilical cord cotinine levels may offer a way to quantitate maternal cigarette consumption in a population in which a maternal history or a maternal sample may be difficult to obtain because of lack of prenatal care and illicit-drag use.
There is conflicting evidence on the effects of high maternal coffee consumption upon birth weight (5) . Tachyarrhythmias, premature atrial contractions, fine tremors, and tachypnea were reported in neonates born to mothers consuming more than 500 rag/day of caffeine (24) . In this study, maternal caffeine consumption was universal, but only two neonates, one in each cohort, had a plasma caffeine level similar to an adult who consumes more than 500 rag/day of caffeine. These data suggest that caffeine is probably not a major confounder for the fetal effects of cocaine.
In summary, our study measured cocaine, BZE, nicotine, cotinine, and caffeine in neonatal plasma and urine. The concentrations of cocaine and BZE were high enough to raise the possibility of pharmacologic effects during the early neonatal period. Any analysis of cocaine effects on fetal development and neonatal behavior should consider the possibility of stimulant drug interactions between cocaine and nicotine and possibly caffeine. Quantitative levels may offer a way to quantitate exposure. Further research is needed to determine the pharmacokinetics of cocaine and metabolites in the neonate and to investigate the relationship between plasma or urine levels and clinical effects.
